Dr. Gordon reported on the study he and Naviaux did in ME/CFS that he expects to be published in the fall. They are now engaged in a larger study
http://www.gordonmedical.com/unrave...unding-replication-study-on-cfidsme-findings/
Gordon and Naviaux will also begin a similar post-Lyme study in the fall. My guess is that they expect to find a similar chemical signature. Gordon was quite honest about his effectiveness treating these diseases.
http://www.gordonmedical.com/unrave...unding-replication-study-on-cfidsme-findings/
Dr. Robert Naviaux and I have submitted for publication a study, now under peer review and expected to be published in the fall of 2016, looking at 450 metabolites in 43 people with CFIDS/ME and 43 age and sex matched controls. We found a characteristic chemical signature differentiating the patients from the controls.
We just received a grant, that along with donations to our newly established non-profit, will allow us to replicate this study. If our findings are indeed replicated we will have a biochemical test for CFIDS/ME.
Gordon and Naviaux will also begin a similar post-Lyme study in the fall. My guess is that they expect to find a similar chemical signature. Gordon was quite honest about his effectiveness treating these diseases.
Our plan is to start enrolling Gordon Medical patients this Fall in a “post Lyme”metabolomic study. This study will biochemically define chronic Lyme disease and if large enough, allow us to define subgroups of these patients.
Some day soon, I envision us able to use the groupings to predict appropriate treatment regimes. At the current time I have good track record in treating treatment resistant chronic Lyme patients who can afford to stay near my clinic for long periods of time and try multiple therapies. This is wasteful of resources and stressful to the patient. It also limits treatment to the wealthy. Currently it is the best we can do, but we need to do much better.